Healthcare and Regulatory Affairs

The Healthcare and Regulatory Affairs team at Priothera is responsible for overseeing the clinical development and regulatory compliance of sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies. They ensure that clinical trials adhere to regulatory standards, manage medical guidance and clinical operations, and support the overall strategy to bring new therapies to market safely and effectively.